EUVIMEDEUVIMED entdecken
Open Access

A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan

Keiji Matsunaga, Mariko Harada-Shiba, Shizuya Yamashita, Hayato Tada, Akihito Uda, Katsuya Mori, Mizuki Yoshimura, Sachie Inoue, Isao Kamae, Shinji Yokoyama, Tetsuo Minamino

Journal of Atherosclerosis and Thrombosis · 01.08.2025 · 32 (8) · 962-981

DOI: 10.5551/jat.65181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.08.2025. Verfasst von Keiji Matsunaga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Hyperlipoproteinemia Type II, Mass Screening. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisHyperlipoproteinemia Type IIMass ScreeningHumansChildJapanMaleFemaleQuality-Adjusted Life YearsAdultMarkov ChainsCardiovascular DiseasesFamilyHydroxymethylglutaryl-CoA Reductase InhibitorsMiddle AgedCost-Effectiveness Analysis

Stichwörter der Autor:innen

Cost-effectivenessFamilial hypercholesterolemiaHealth economicsReverse cascade screeningUniversal screening

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University.
  • Cardiovascular Center, Osaka Medical and Pharmaceutical University.
  • Rinku General Medical Center.
  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University.
  • Novartis Pharma K.K.
  • CRECON Medical Assessment Inc.

Zitieren

APA

Matsunaga, K., Harada-Shiba, M., Yamashita, S., Tada, H., Uda, A., Mori, K., Yoshimura, M., Inoue, S., Kamae, I., Yokoyama, S., & Minamino, T. (2025). A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan. Journal of Atherosclerosis and Thrombosis, 32(8), 962-981. https://doi.org/10.5551/jat.65181

Vancouver

Matsunaga K, Harada-Shiba M, Yamashita S, Tada H, Uda A, Mori K, et al. A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan. Journal of Atherosclerosis and Thrombosis. 2025;32(8):962-981. doi:10.5551/jat.65181

BibTeX
@article{Matsunaga2025,
  author = {Matsunaga, Keiji and Harada-Shiba, Mariko and Yamashita, Shizuya and Tada, Hayato and Uda, Akihito and Mori, Katsuya and Yoshimura, Mizuki and Inoue, Sachie and Kamae, Isao and Yokoyama, Shinji and Minamino, Tetsuo},
  title = {A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  volume = {32},
  number = {8},
  pages = {962--981},
  doi = {10.5551/jat.65181}
}
Kostenlos starten →